International Journal of Medical and Health Research

International Journal of Medical and Health Research


International Journal of Medical and Health Research
International Journal of Medical and Health Research
Vol. 6, Issue 3 (2020)

Post marketing surveillance on safety and efficacy of Cymbi oral drops in various gastrointestinal indications: A survey-based study


KP Mahesh, Raghavendra KV, Manoj Kumar Yadava

Background: With the increase of acid suppressant medicine uses and many raised questions regarding the safety and efficacy of these agents, the present questionnaire-based survey was designed to access the safety and efficacy of Cymbi oral drop manufactured by Juggat Pharma, Bangalore against various gastrointestinal (GI) indications. Method: A structured format survey consisting of an inventory chart for items that contain voluntary consent of doctors to participate in the survey, demographic details of doctors and safety, and efficacy parameter questionnaire which had 13 questions were distributed to doctors across PAN India. The completed survey forms were collected, and the answers to the questionnaire were analyzed and interpreted. Results: There was a total of 288 completed questionnaire forms received across PAN India. Out of 288 doctors who took this questionnaire-survey based study, 255 doctors did not notice any side-effects in infants and children following the administration of Cymbi. 87.5% of doctors did not notice any interaction of Cymbi oral drop with food. In our survey, the majority of doctors i.e. 67.4% who took the questionnaire survey rated the efficacy of Cymbi in infants and children was much better than before medication with Cymbi. 279 out of 288 doctors reckoned that the product Cymbi was safe enough for the oral administration in infants and children, and 84.4% who took a survey prefer to prescribe Cymbi oral drop for infants and children over all the other options they have available against GI disorders. Conclusion: The present survey demonstrated that Cymbi oral drop at the recommended dose was safe and efficacious in the treatment of GI disorders viz. infant colic pain, griping pain, flatulence, and bloating without any side-effects.
Download  |  Pages : 153-158
How to cite this article:
KP Mahesh, Raghavendra KV, Manoj Kumar Yadava. Post marketing surveillance on safety and efficacy of Cymbi oral drops in various gastrointestinal indications: A survey-based study. International Journal of Medical and Health Research, Volume 6, Issue 3, 2020, Pages 153-158
International Journal of Medical and Health Research